By proceeding, you agree to our Terms of Use and Privacy Policy.
Revolutionizing Drug Discovery & Development with Advanced 3D Models In light of recent advancements, including the FDA Modernization Act 2.0 signed by President Biden in December 2022, the successful IND approval for a Phase 2 clinical trial using organ-on-chip data by Hesperos and Sanofi, and NIH's development of in vitro models for AMD using bioprinting of eye tissue, drug discovery and development experts will reunite in Boston in May 2023 for the 8th Annual 3D Tissue Models Summit. This conference is a crucial opportunity for drug developers to explore and integrate complex 3D models with over 24 real-life case studies across two dedicated tracks, providing valuable lessons learned. What Sets the 8th 3D Tissue Models Summit Apart? This industry-focused summit is the only one of its kind, with a focus on real-world applications for drug discovery and development within an industrial and regulatory environment. It is not only for educational purposes but also for promoting pre-competitive collaboration. Attendees will have the opportunity to exchange challenges, inspire solutions, and assess the latest technologies in a unique platform designed specifically for drug developers.
Discover the latest advances in 3D tissue modeling to empower drug discovery & development.
Learn from the experts and dive into real-world drug discovery and development applications with an industrial and regulatory environment in mind.
Explore the potential of 3D tissue models. Network with pharmaceutical and biotech industry professionals & attend workshops & interactive sessions.
Garb the unique opportunity to be part of the drug developers community & exchange challenges, inspire solutions, and assess the latest technologies.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Corning is one of the world's leading innovators in materials science, with a 167-year track record of life-changing inventions.
AnaBios generates highly valuable, predictive human data in advance of clinical trials, ensuring the selection of the most effective and safest drugs, thereby reducing the time and expense related to clinical trial failures.
CELLINK is proud to be a part of BICO, the world’s leading bioconvergence company.
Curi Bio is accelerating the discovery of the next generation of medicines by integrating human cells, systems, and data.
SCREEN Americas (Elk Grove Village, Illinois), a SCREEN Graphic and Precision Solutions group company, provides a wide range of solutions to meet graphic communications needs, with a strong focus on production-class inkjet printing technology.
Boston Micro Fabrication (BMF) specializes in micro precision 3D printing.
At Promega Corporation, creativity and connection drive discovery and innovation. We celebrate scientific discovery and the creative application of science to solve problems.
Molecular Devices is one of the world’s leading providers of high-performance life science technology.
Driven by cutting-edge science, Diagnostic Research Laboratory ( DRL), the premier source for annotated human biospecimens, has recently initiated a new program – the establishment of patient-derived tumor organoid cultures from tumor biopsies and su
Driven by cutting-edge science, Diagnostic Research Laboratory ( DRL), the premier source for annotated human biospecimens, has recently initiated a new program – the establishment of patient-derived tumor organoid cultures from tumor biopsies and surgically resected tissues (lung, colon, or ovarian
Advanced Solutions Life Sciences (ASLS) is dedicated to the discovery, design, and development of integrated software and hardware solutions for the fields of science that involve living organisms, molecular biology, and biotechnology. ASLS offers a
Advanced Solutions Life Sciences (ASLS) is dedicated to the discovery, design, and development of integrated software and hardware solutions for the fields of science that involve living organisms, molecular biology, and biotechnology. ASLS offers a full service business model including its patent p
BioSurfaces, LLC seeks to improve the quality of medical care by augmenting existing and emerging medical approaches with our cutting-edge nanotechnology. The use of yesterday’s technology in today’s medical devices causes unacceptable complication
BioSurfaces, LLC seeks to improve the quality of medical care by augmenting existing and emerging medical approaches with our cutting-edge nanotechnology. The use of yesterday’s technology in today’s medical devices causes unacceptable complication rates and fatalities. The direct implementation o
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.